Evidence map›Paper›PMID 37504350›Full record

Observational studyCurrent oncology (Toronto, Ont.)2023

Imaging Spectrum of the Developing Glioblastoma: A Cross-Sectional Observation Study.

Stuart Currie, Kavi Fatania, Russell Frood, Ruth Whitehead, Joanna Start, Ming-Te Lee, Benjamin McDonald, Kate Rankeillor, Paul Roberts, Aruna Chakrabarty and 4 more

Abstract readObservational Study
In one paragraph

Observational study in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Stuart CurrieDepartment of Neuroradiology, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Floor B, Clarendon Wing, Great George Street, Leeds LS1 3EX, UK.ORCID 0000-0002-0154-6588
Kavi FataniaRadiology Academy, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Floor B, Clarendon Wing, Great George Street, Leeds LS1 3EX, UK.ORCID 0000-0003-2421-1083
Russell FroodRadiology Academy, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Floor B, Clarendon Wing, Great George Street, Leeds LS1 3EX, UK.ORCID 0000-0003-2681-9922
Ruth WhiteheadRadiology Academy, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Floor B, Clarendon Wing, Great George Street, Leeds LS1 3EX, UK.
Joanna StartRadiology Academy, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Floor B, Clarendon Wing, Great George Street, Leeds LS1 3EX, UK.ORCID 0000-0003-2025-2056
Ming-Te LeeRadiology Academy, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Floor B, Clarendon Wing, Great George Street, Leeds LS1 3EX, UK.
Benjamin McDonaldDepartment of Histopathology, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds LS9 7TF, UK.
Kate RankeillorDepartment of Histopathology, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds LS9 7TF, UK.
Paul RobertsDepartment of Histopathology, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds LS9 7TF, UK.
Aruna ChakrabartyDepartment of Histopathology, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds LS9 7TF, UK.
Ryan K MathewDepartment of Neurosurgery, Leeds Teaching Hospitals NHS Trust, Leeds General Infirmary, Floor G, Jubilee Wing, Great George Street, Leeds LS1 3EX, UK.ORCID 0000-0002-2609-9876
Louise MurrayLeeds Institute of Medical Research, University of Leeds, Leeds LS2 9TJ, UK.
Susan ShortLeeds Institute of Medical Research, University of Leeds, Leeds LS2 9TJ, UK.
Andrew ScarsbrookLeeds Institute of Medical Research, University of Leeds, Leeds LS2 9TJ, UK.ORCID 0000-0002-4243-032X

Funding

Cancer Research UK 28832Cancer Research UK C19942/A28832Cancer Research UK RCCCTF-OCT22/100002
6 · The paper itself

Abstract

Glioblastoma (GBM) has the typical radiological appearance (TRA) of a centrally necrotic, peripherally enhancing tumor with surrounding edema. The objective of this study was to determine whether the developing GBM displays a spectrum of imaging changes detectable on routine clinical imaging prior to TRA GBM. Patients with pre-operative imaging diagnosed with GBM (1 January 2014-31 March 2022) were identified from a neuroscience center. The imaging was reviewed by an experienced neuroradiologist. Imaging patterns preceding TRA GBM were analyzed. A total of 76 out of 555 (14%) patients had imaging preceding TRA GBM, 57 had solitary lesions, and 19 had multiple lesions (total = 84 lesions). Here, 83% of the lesions had cortical or cortical/subcortical locations. The earliest imaging features for 84 lesions were T2 hyperintensity/CT low density (

Indexed as

GlioblastomaCross-Sectional StudiesHumansMagnetic Resonance ImagingTomography, X-Ray Computedbraincomputed tomographyglioblastomamagnetic resonance imaging

Identifiers

PMID37504350
PMCPMC10378288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.